Source:http://linkedlifedata.com/resource/pubmed/id/10556828
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1999-12-23
|
pubmed:abstractText |
Nur77 is a transcription factor that is induced to a high level during TCR-mediated apoptosis of thymocytes and T cell hybridomas. Expression of a dominant-negative mutant of Nur77 can inhibit TCR-mediated apoptosis, while constitutive expression of full-length Nur77 in thymocytes leads to massive apoptosis. Nur77 is similar to the steroid receptor family and consists of a transactivation, a DNA-binding and a C-terminal "ligand-binding" domain. In contrast to the other nuclear receptors, Nur77 activity does not appear to depend on any ligand. However, its C-terminal region can regulate its transactivation activity. A short C-terminal deletion results in a protein with only 15 - 20% activity while deletion of the entire C-terminal region increases its activity. To further study the role of Nur77 transcription in apoptosis, we have generated transgenic mice expressing Nur77 with a short C-terminal deletion or Nur77 without its entire C-terminal domain. Mice expressing the shorter deletion/transcriptionally less active mutant displayed a mild phenotype. However, mice with the larger deletion/more transcriptionally active mutant showed massive thymocyte apoptosis. These data suggest that Nur77 transcription correlates with its apoptotic function in vivo.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Nr4a1 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Receptor Subfamily 4...,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cytoplasmic and Nuclear,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Steroid,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0014-2980
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3722-8
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:10556828-Animals,
pubmed-meshheading:10556828-Apoptosis,
pubmed-meshheading:10556828-DNA-Binding Proteins,
pubmed-meshheading:10556828-Mice,
pubmed-meshheading:10556828-Mice, Inbred C57BL,
pubmed-meshheading:10556828-Mice, Inbred CBA,
pubmed-meshheading:10556828-Mice, Transgenic,
pubmed-meshheading:10556828-Nuclear Receptor Subfamily 4, Group A, Member 1,
pubmed-meshheading:10556828-Phenotype,
pubmed-meshheading:10556828-Receptors, Cytoplasmic and Nuclear,
pubmed-meshheading:10556828-Receptors, Steroid,
pubmed-meshheading:10556828-Sequence Deletion,
pubmed-meshheading:10556828-T-Lymphocytes,
pubmed-meshheading:10556828-Transcription, Genetic,
pubmed-meshheading:10556828-Transcription Factors,
pubmed-meshheading:10556828-Transgenes
|
pubmed:year |
1999
|
pubmed:articleTitle |
Nur77 transcription activity correlates with its apoptotic function in vivo.
|
pubmed:affiliation |
Department of Molecular Biology, Division of Immunology and Cancer Research Laboratory, 469 LSA, University of California at Berkeley, Berkeley, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|